Blue Ox Healthcare Partners, LLC - 18 Jul 2022 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Reporting relationship: 10%+ Owner
Issuer ticker: SERA
Reported as of: 18 Jul 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Jul 2022, 17:20:26 UTC
Prior SEC filing: 21 Jul 2021
Source filing: View source filing
Reporting owner signature: Blue Ox Healthcare Partners, LLC /s/ John A. Neczesny, Secretary

Key filing fact

Blue Ox Healthcare Partners, LLC filed Form 4 for SERA PROGNOSTICS, INC. (SERA) on 19 Jul 2022.

Key facts

This page summarizes Blue Ox Healthcare Partners, LLC's Form 4 filing for SERA PROGNOSTICS, INC. (SERA).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Jul 2022, 17:20.

Change

Previous filing in this sequence was filed on 21 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SERA transaction

Class A Common Stock

Other

Transaction value: $0
Shares: -1,383,094
Change %: -91%
Price: $0.000000
Shares after: 132,501
Date: 18 Jul 2022
Ownership: By Blue Ox Healthcare Partners SP, LLC
Footnotes: F1, F2

SERA transaction

Class A Common Stock

Other

Transaction value: $0
Shares: -997,627
Change %: -93%
Price: $0.000000
Shares after: 77,420
Date: 18 Jul 2022
Ownership: By BXHCP SP II, LLC
Footnotes: F1, F2

SERA transaction

Class A Common Stock

Other

Transaction value: $0
Shares: -1,157,764
Change %: -96%
Price: $0.000000
Shares after: 46,744
Date: 18 Jul 2022
Ownership: By BXHCP SP III, LLC
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Blue Ox Healthcare Partners, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements.

Footnote F2

Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares.